Cargando…

A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma

BACKGROUND: Deregulation of the RNA polymerase III specific TFIIIB subunit BRF2 occurs in subtypes of human cancers. However, correlations between BRF2 alterations and clinical outcomes in breast cancer are limited. We conducted this review to analyze BRF2 alterations in genomic data sets housed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabarcas-Petroski, Stephanie, Meneses, Patricio I., Schramm, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659115/ https://www.ncbi.nlm.nih.gov/pubmed/33176745 http://dx.doi.org/10.1186/s12885-020-07569-8

Ejemplares similares

Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells
por: Cabarcas, Stephanie, et al.
Publicado: (2008)

Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein
por: Koo, Jana, et al.
Publicado: (2015)

RNA polymerase III transcription in cancer: the BRF2 connection
por: Cabarcas, Stephanie, et al.
Publicado: (2011)

Human Maf1 negatively regulates RNA Polymerase III transcription via the TFIIB family members Brf1 and Brf2
por: Rollins, Janet, et al.
Publicado: (2007)

MAF1 is a predictive biomarker in HER2 positive breast cancer
por: Cabarcas-Petroski, Stephanie, et al.
Publicado: (2023)

Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas
por: Hinić, Snežana, et al.
Publicado: (2022)

BDP1 Alterations Correlate with Clinical Outcomes in Breast Cancer
por: Cabarcas-Petroski, Stephanie, et al.
Publicado: (2022)

BDP1 as a biomarker in serous ovarian cancer
por: Cabarcas‐Petroski, Stephanie, et al.
Publicado: (2022)

The significance of Brf1 overexpression in human hepatocellular carcinoma
por: Zhong, Qian, et al.
Publicado: (2015)

Alcohol Intake and Abnormal Expression of Brf1 in Breast Cancer
por: Huang, Chenghao, et al.
Publicado: (2019)

Bromine Pentafluoride BrF(5), the Formation of [BrF(6)](−) Salts, and the Stereochemical (In)activity of the Bromine Lone Pairs
por: Möbs, Martin, et al.
Publicado: (2022)

Targeting BRF2 in Cancer Using Repurposed Drugs
por: Rashidieh, Behnam, et al.
Publicado: (2021)

BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration
por: Loveridge, Carolyn J., et al.
Publicado: (2019)

BRF Negatively Regulates Thermotolerance Defect of fes1a in Arabidopsis
por: Fu, Can, et al.
Publicado: (2020)

Role of Brf1 interaction with ERα, and significance of its overexpression, in human breast cancer
por: Fang, Zeng, et al.
Publicado: (2017)

Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration
por: Loveridge, Carolyn J., et al.
Publicado: (2019)

Silencing of BRF2 inhibits the growth and metastasis of lung cancer cells
por: Bian, Yuan, et al.
Publicado: (2020)

Redox Signaling by the RNA Polymerase III TFIIB-Related Factor Brf2
por: Gouge, Jerome, et al.
Publicado: (2015)

Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas
por: Liko, Dritan, et al.
Publicado: (2019)

A novel BRF1 mutation in two middle-aged siblings with cerebellofaciodental syndrome
por: Zhao, Xin, et al.
Publicado: (2022)

Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma
por: Lockwood, William W., et al.
Publicado: (2010)

Release factor-dependent ribosome rescue by BrfA in the Gram-positive bacterium Bacillus subtilis
por: Shimokawa-Chiba, Naomi, et al.
Publicado: (2019)

Participation of TFIIIB Subunit Brf1 in Transcription Regulation in the Human Pathogen Leishmania major
por: Florencio-Martínez, Luis E., et al.
Publicado: (2021)

ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma
por: ling, Jie, et al.
Publicado: (2022)

BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway
por: Chang, Jian-Hua, et al.
Publicado: (2023)

BRF1 mutations alter RNA polymerase III–dependent transcription and cause neurodevelopmental anomalies
por: Borck, Guntram, et al.
Publicado: (2015)

BRF1 ameliorates LPS-induced inflammation through autophagy crosstalking with MAPK/ERK signaling
por: Xie, Weiwei, et al.
Publicado: (2018)

ROS Signaling-Mediated Novel Biological Targets: Brf1 and RNA Pol III Genes
por: Zheng, Liling, et al.
Publicado: (2021)

CellBRF: a feature selection method for single-cell clustering using cell balance and random forest
por: Xu, Yunpei, et al.
Publicado: (2023)

Sand Dune Ridge Alignment Effects on Surface BRF over the Libya-4 CEOS Calibration Site
por: Govaerts, Yves M.
Publicado: (2015)

MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line
por: Wang, Lei, et al.
Publicado: (2018)

Spécification technique pour le tableau de distribution BT: Destine a la salle BRF2/booster
Publicado: (1981)

New tricks for an old dog: Brf2-dependent RNA Polymerase III transcription in oxidative stress and cancer
por: Gouge, Jerome, et al.
Publicado: (2017)

Functional Characterization of BrF3'H, Which Determines the Typical Flavonoid Profile of Purple Chinese Cabbage
por: Park, Sangkyu, et al.
Publicado: (2021)

Exploring the Role and Mechanism of pAMPKα-Mediated Dysregulation of Brf1 and RNA Pol III Genes
por: Wu, Teng, et al.
Publicado: (2021)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma
por: Zhou, Jiawei, et al.
Publicado: (2021)

Analysis of Prognostic Factors and Construction of Prognostic Models for Invasive Micropapillary Carcinoma of the Breast
por: Wang, Xinli, et al.
Publicado: (2022)

A novel function of Tis11b/BRF1 as a regulator of Dll4 mRNA 3′-end processing
por: Desroches-Castan, Agnès, et al.
Publicado: (2011)

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment
por: Chen, Yanzhu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3rulv1ug93ko8ghd50bfbip87j